<--- Back to Details
First PageDocument Content
Imatinib / Pyridines / Cancer treatments / Chronic myelogenous leukemia / Leukemia / Compliance / Chemotherapy / Medicine / Piperazines / Pyrimidines
Date: 2011-08-10 00:52:56
Imatinib
Pyridines
Cancer treatments
Chronic myelogenous leukemia
Leukemia
Compliance
Chemotherapy
Medicine
Piperazines
Pyrimidines

Add to Reading List

Source URL: supportivecancercarevictoria.org

Download Document from Source Website

File Size: 86,36 KB

Share Document on Facebook

Similar Documents

MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

DocID: 1vhjk - View Document

Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave

DocID: 1vcJH - View Document

Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version

DocID: 1v6bB - View Document

The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

DocID: 1uSbg - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document